amphetamine has been researched along with Neonatal Abstinence Syndrome in 4 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Neonatal Abstinence Syndrome: Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. Withdrawal or abstinence symptoms develop shortly after birth. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a tertiary neonatal care center in Taiwan, three neonates whose mothers self-reported heroin abuse with methadone treatment during pregnancy were studied." | 7.78 | Perinatal effects of combined use of heroin, methadone, and amphetamine during pregnancy and quantitative measurement of metabolites in hair. ( Chang, YZ; Chen, JY; Chen, SC; Ng, YY; Su, PH; Yang, C, 2012) |
| "In a tertiary neonatal care center in Taiwan, three neonates whose mothers self-reported heroin abuse with methadone treatment during pregnancy were studied." | 3.78 | Perinatal effects of combined use of heroin, methadone, and amphetamine during pregnancy and quantitative measurement of metabolites in hair. ( Chang, YZ; Chen, JY; Chen, SC; Ng, YY; Su, PH; Yang, C, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Su, PH | 1 |
| Chang, YZ | 1 |
| Yang, C | 1 |
| Ng, YY | 1 |
| Chen, JY | 1 |
| Chen, SC | 1 |
| Eriksson, M | 1 |
| Jonsson, B | 1 |
| Steneroth, G | 1 |
| Zetterström, R | 1 |
| Struthers, JM | 1 |
| Hansen, RL | 1 |
| Klöppel, A | 1 |
| Weiler, G | 1 |
4 other studies available for amphetamine and Neonatal Abstinence Syndrome
| Article | Year |
|---|---|
Perinatal effects of combined use of heroin, methadone, and amphetamine during pregnancy and quantitative measurement of metabolites in hair.
Topics: Adult; Amphetamine; Electroencephalography; Female; Fetus; Gas Chromatography-Mass Spectrometry; Hai | 2012 |
Amphetamine abuse during pregnancy: environmental factors and outcome after 14-15 years.
Topics: Adolescent; Amphetamine; Child; Child Behavior Disorders; Cohort Studies; Developmental Disabilities | 2000 |
Visual recognition memory in drug-exposed infants.
Topics: Amphetamine; Cocaine; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Intelligence Tests | 1992 |
[Diaplacental poisoning with narcotics and alcohol in newborn infants].
Topics: Amphetamine; Cause of Death; Cocaine; Ethanol; Female; Fetal Alcohol Spectrum Disorders; Humans; Inf | 1989 |